Avoro Capital Advisors LLC Argenx Se Transaction History

Avoro Capital Advisors LLC

$7.32 Billion
Q3 2025

A detailed history of Avoro Capital Advisors LLC transactions in Argenx Se stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 990,000 shares of ARGX stock, worth $899 Million. This represents 9.98% of its overall portfolio holdings.

Number of Shares

990,000

Previous 1,175,000 15.74%

Holding current value

$899 Million

Previous $648 Million 12.74%

% of portfolio

9.98%

Previous 11.81%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$538.64 - $768.0 $99.6 Million - $142 Million	-185,000 Reduced 15.74%	990,000 $730 Million
Q2 2025 Aug 14, 2025	SELL	$532.27 - $656.65 $32 Million - $39.5 Million	-60,177 Reduced 4.87%	1,175,000 $648 Million
Q1 2025 May 15, 2025	SELL	$571.0 - $671.75 $1.88 Million - $2.21 Million	-3,290 Reduced 0.27%	1,235,177 $731 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $1.39 Million - $1.61 Million	3,900 Added 0.32%	1,238,467 $488 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $79.5 Million - $119 Million	234,567 Added 23.46%	1,234,567 $470 Million

Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $97.3 Million - $145 Million	-263,500 Reduced 20.85%	1,000,000 $492 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $8.64 Million - $10.1 Million	-24,000 Reduced 1.86%	1,263,500 $492 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $7.33 Million - $8.86 Million	21,945 Added 1.73%	1,287,500 $480 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $2.85 Million - $4 Million	10,555 Added 0.84%	1,265,555 $479 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $73.8 Million - $102 Million	290,000 Added 30.05%	1,255,000 $396 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $5.03 Million - $6.53 Million	18,500 Added 1.95%	965,000 $338 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $5.4 Million - $6.72 Million	21,000 Added 2.27%	946,500 $285 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $6.17 Million - $8.75 Million	23,000 Added 2.55%	925,500 $255 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $14.5 Million - $18.4 Million	-67,500 Reduced 6.96%	902,500 $237 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $4.27 Million - $7.8 Million	33,500 Added 3.58%	970,000 $218 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $10.8 Million - $16.7 Million	101,500 Added 12.16%	936,500 $150 Million
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $566,550 - $752,550	-5,000 Reduced 0.6%	835,000 $95.2 Million
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $1.98 Million - $2.69 Million	-20,000 Reduced 2.33%	840,000 $105 Million
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $6.67 Million - $11.5 Million	104,585 Added 13.84%	860,000 $82.6 Million
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $2.01 Million - $2.57 Million	-26,638 Reduced 3.41%	755,415 $57.3 Million
Q2 2018 Aug 14, 2018	SELL	$74.84 - $100.16 $6.08 Million - $8.14 Million	-81,222 Reduced 9.41%	782,053 $64.8 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $3.33 Million - $4.98 Million	58,400 Added 7.26%	863,275 $69.4 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $8.47 Million - $23.9 Million	375,275 Added 87.35%	804,875 $50.8 Million
Q3 2017 Nov 14, 2017	BUY	$19.81 - $22.61 $8.51 Million - $9.71 Million	429,600	429,600 $9.71 Million

Others Institutions Holding ARGX

# of Institutions

528

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Argenx Se Transaction History